{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T10:12:15Z","timestamp":1768644735367,"version":"3.49.0"},"reference-count":19,"publisher":"Termedia Sp. z.o.o.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pol J Radiol"],"abstract":"Purpose<\/jats:title>We present the outcomes of microwave ablation (MWA) of renal cell carcinoma (RCC) with and without pyeloperfusion.<\/jats:p><\/jats:sec>Material and methods<\/jats:title>A retrospective review of patients\u2019 records was undertaken to identify patients with RCC, who were treated with MWA with and without adjunctive pyeloperfusion. The distance between the tumour and ureter as well as the tumour size were measured on axial imaging. Pyeloperfusion was performed in nine patients in this series after placement of a ureteral stent and instilment of diluted contrast into the ureter. MWAs of the tumours were performed under computed tomography (CT) guidance. Hydrodissection was performed to displace at-risk organs. Crea\u00adtinine was measured as renal function index after and before the procedure. A CT scan was performed at the end of the procedure and also after one, three, and six months, to identify the presence of residual disease and complications.<\/jats:p><\/jats:sec>Results<\/jats:title>Eighteen biopsies of proven RCC were treated with 20 sessions of MWA. The average follow-up time for this study was 180 days. The average distance between the ureter and the tumour in axial CT view was 20.8 (\u00b1 2.9) mm. Primary efficacy was achieved in 88% of pyeloperfused patients and in 100% of the non-pyeloperfused patients. Two pyeloperfused patients required secondary procedure, and full secondary efficacy was achieved for both. There was only one grade 2 urological complication, which occurred in a patient who underwent pyeloperfusion. Creatinine was not significantly different after the procedure in this study (p-value 0.4).<\/jats:p><\/jats:sec>Conclusion<\/jats:title>In this study MWAs of RCCs were successfully performed using pyeloperfusion as a protective measure against thermal injury to the ureter.<\/jats:p><\/jats:sec>","DOI":"10.5114\/pjr.2019.89966","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T08:52:01Z","timestamp":1575363121000},"page":"447-452","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of clinical outcome between pyeloperfused <i><i><i><i>versus<\/i><\/i><\/i><\/i> non-pyeloperfused microwave ablation of renal cell carcinoma"],"prefix":"10.5114","volume":"84","author":[{"given":"Katayoun","family":"Samadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Arellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3061","published-online":{"date-parts":[[2019,11,8]]},"reference":[{"key":"ref-1139393","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2214\/ajr.185.1.01850064","article-title":"Radiofrequency ablation of renal cell carcinoma: Part 1. Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors","volume":"185","author":"Gervais DA","year":"2005","unstructured":"Gervais DA, McGovern FJ, Arellano RS, et al. (2005). Radiofrequency ablation of renal cell carcinoma: Part 1. Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Am J Roentgenol. 185: 64-71.","journal-title":"Am J Roentgenol"},{"key":"ref-1139394","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.juro.2009.07.004","article-title":"Guideline for management of the clinical T1 renal mass","volume":"182","author":"Campbell SC","year":"2009","unstructured":"Campbell SC, Novick AC, Belldegrun A, et al. (2009). Guideline for management of the clinical T1 renal mass. J Urol. 182: 1271-1279.","journal-title":"J Urol"},{"key":"ref-1139395","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1464-410X.2011.10885.x","article-title":"Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies","volume":"110","author":"El Dib R","year":"2012","unstructured":"El Dib R, Touma NJ, Kapoor A. (2012). Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies. BJU Int. 110: 510-516.","journal-title":"BJU Int"},{"key":"ref-1139396","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.eururo.2014.07.021","article-title":"Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses","volume":"67","author":"Thompson RH","year":"2015","unstructured":"Thompson RH, Atwell T, Schmit G, et al. (2015). Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 67: 252-259.","journal-title":"Eur Urol"},{"key":"ref-1139397","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejrad.2009.12.009","article-title":"A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers","volume":"79","author":"Yu J","year":"2011","unstructured":"Yu J, Liang P, Yu X, et al. (2011). A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers. Eur J Radiol. 79: 124-130.","journal-title":"Eur J Radiol"},{"key":"ref-1139398","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijsu.2008.12.028","article-title":"Microwave tumors ablation: principles, clinical applications and review of preliminary experiences","volume":"1","author":"Carrafiello G","year":"2008","unstructured":"Carrafiello G, Lagana D, Mangini M, et al. (2008). Microwave tumors ablation: principles, clinical applications and review of preliminary experiences. Int J Surg. 1: 65-69.","journal-title":"Int J Surg"},{"key":"ref-1139399","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.juro.2008.05.012","article-title":"Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience","volume":"180","author":"Liang P","year":"2008","unstructured":"Liang P, Wang Y, Zhang D, et al. (2008). Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience. J Urol. 180: 844-848.","journal-title":"J Urol"},{"key":"ref-1139400","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1148\/radiol.12111209","article-title":"US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results","volume":"263","author":"Yu J","year":"2012","unstructured":"Yu J, Liang P, Yu XL, et al. (2012). US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results. Radiology. 263: 900-908.","journal-title":"Radiology"},{"key":"ref-1139401","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.jvir.2008.04.005","article-title":"Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion wit cooled dextrose 5% in water","volume":"19","author":"Cantwell CP","year":"2008","unstructured":"Cantwell CP, Wah TM, Gervais DA, et al. (2008). Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion wit cooled dextrose 5% in water. Vasc Interv Radiol. 19: 1034-1040.","journal-title":"Vasc Interv Radiol"},{"key":"ref-1139402","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jvir.2017.05.006","article-title":"Image-guided percutaneous radiofrequency ablation of central renal cell carcinoma: assessment of clinical efficacy and safety in 31 tumors","volume":"28","author":"Dai Y","year":"2017","unstructured":"Dai Y, Covarrubias D, Uppot R, et al. (2017). Image-guided percutaneous radiofrequency ablation of central renal cell carcinoma: assessment of clinical efficacy and safety in 31 tumors. J Vasc Interv Radiol. 28: 1643-1650.","journal-title":"J Vasc Interv Radiol"},{"key":"ref-1139403","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo D","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. (2004). Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 240: 205-213.","journal-title":"Ann Surg"},{"key":"ref-1139404","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1089\/end.2008.0135","article-title":"Central and deep renal tumors can be effectively ablated: radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring","volume":"22","author":"Wingo MS","year":"2008","unstructured":"Wingo MS, Leveillee RJ. (2008). Central and deep renal tumors can be effectively ablated: radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring. J Endourol. 22: 1261-1267.","journal-title":"J Endourol"},{"key":"ref-1139405","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1148\/radiol.2361031249","article-title":"Radiofrequency versus microwave ablation in a hepatic porcine model","volume":"236","author":"Wright AS","year":"2005","unstructured":"Wright AS, Sampson LA, Warner TF, et al. (2005). Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology. 236: 132-139.","journal-title":"Radiology"},{"key":"ref-1139406","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2214\/ajr.185.1.01850064","article-title":"Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors","volume":"185","author":"Gervais DA","year":"2005","unstructured":"Gervais DA, McGovern FJ, Arellano RS, et al. (2005). Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 185: 64-71.","journal-title":"AJR Am J Roentgenol"},{"key":"ref-1139407","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s11604-010-0451-z","article-title":"Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma","volume":"28","author":"Takaki H","year":"2010","unstructured":"Takaki H, Yamakado K, Soga N, et al. (2010). Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma. Jpn J Radiol. 28: 460-468.","journal-title":"Jpn J Radiol"},{"key":"ref-1139408","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.juro.2012.08.180","article-title":"Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors","volume":"189","author":"Schmit GD","year":"2013","unstructured":"Schmit GD, Thompson RH, Kurup AN, et al. (2013). Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors. J Urol. 189: 30-35.","journal-title":"J Urol"},{"key":"ref-1139409","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.2147\/OTT.S109783","article-title":"Complications of ultrasound-guided percutaneous microwave ablation of renal cell carcinoma","volume":"9","author":"Dong X","year":"2016","unstructured":"Dong X, Yu X, Yu M, et al. (2016). Complications of ultrasound-guided percutaneous microwave ablation of renal cell carcinoma. Onco Targets Ther. 9: 5903-5909.","journal-title":"Onco Targets Ther"},{"key":"ref-1139410","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.urology.2010.12.028","article-title":"Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up","volume":"77","author":"Castle SM","year":"2011","unstructured":"Castle SM, Salas N, Leveillee RJ. (2011). Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up. Urology. 77: 792-797.","journal-title":"Urology"},{"key":"ref-1139411","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/bju.12349","article-title":"Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours","volume":"113","author":"Wah T","year":"2014","unstructured":"Wah T, Irving H, Gregory W, et al. (2014). Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int. 113: 416-428.","journal-title":"BJU Int"}],"container-title":["Polish Journal of Radiology"],"original-title":[],"link":[{"URL":"https:\/\/www.polradiol.com\/pdf-112925-108742","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.polradiol.com\/pdf-112925-108742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T11:32:01Z","timestamp":1716377521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.polradiol.com\/Comparison-of-clinical-outcome-between-pyeloperfused-versus-non-pyeloperfused-microwave,112925,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,8]]},"references-count":19,"alternative-id":["112925"],"URL":"https:\/\/doi.org\/10.5114\/pjr.2019.89966","relation":{},"ISSN":["1899-0967"],"issn-type":[{"value":"1899-0967","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,8]]}}}